Related Experiment Video
Updated: Jan 3, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this
Aurélie Caye1,2, Kevin Rouault-Pierre3,4, Marion Strullu1,2
1INSERM UMR_S1131, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
Abstract:
Juvenile myelomonocytic leukemia (JMML) is a rare aggressive myelodysplastic/myeloproliferative neoplasm of early childhood, initiated by RAS-activating mutations. Genomic analyses have recently described JMML mutational landscape; however, the nature of JMML-propagating cells (JMML-PCs) and the clonal architecture of the disease remained until now elusive. Combining genomic (exome, RNA-seq), Colony forming assay and xenograft studies, we detect the presence of JMML-PCs that faithfully reproduce JMML features including the complex/nonlinear organization of dominant/minor clones, both at diagnosis and relapse. Further integrated analysis also reveals that although the mutations are acquired in hematopoietic stem cells, JMML-PCs are not always restricted to this compartment, highlighting the heterogeneity of the disease during the initiation steps. We show that the hematopoietic stem/progenitor cell phenotype is globally maintained in JMML despite overexpression of CD90/THY-1 in a subset of patients. This study shed new lights into the ontogeny of JMML, and the identity of JMML-PCs, and provides robust models to monitor the disease and test novel therapeutic approaches.
Insights
This study identifies the specific Juvenile myelomonocytic leukemia-propagating cells (JMML-PCs) responsible for disease initiation and progression. These cells maintain disease features across diagnosis and relapse, offering new therapeutic targets.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Juvenile myelomonocytic leukemia (JMML) is a rare, aggressive childhood cancer driven by RAS mutations.
- The identity of JMML-propagating cells (JMML-PCs) and the disease's clonal structure have remained unclear.
Purpose of the Study:
- To identify JMML-PCs and elucidate the clonal architecture of JMML.
- To understand the cellular origins and heterogeneity of JMML.
Main Methods:
- Genomic analyses including exome sequencing and RNA-seq.
- Colony-forming assays and xenograft studies.
- Integrated analysis of multi-omics data.
Main Results:
- JMML-PCs were identified and shown to faithfully reproduce JMML characteristics.
- Complex clonal organization (dominant/minor clones) was observed at diagnosis and relapse.
- JMML-PCs are not exclusively confined to hematopoietic stem cells, indicating disease heterogeneity.
Conclusions:
- This research clarifies the ontogeny of JMML and the identity of JMML-PCs.
- The findings provide models for disease monitoring and therapeutic development.
- Understanding JMML-PC heterogeneity is crucial for effective treatment strategies.
More Related Videos
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Lineage Commitment
Differentiation of Common Myeloid Progenitor Cells
Hematopoiesis
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Regulation of Hematopoietic Stem Cells

